Clinical trial
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive…
NCT00229385 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00229385 |
|---|---|
| Title | Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) |
| Official title | Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Obsessive Compulsive Disorder |
| Intervention type | Drug |
| Interventions | Ziprasidone |
| Enrollment | 45 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2010 |
| First posted | Sep 29, 2005 |
| Last update posted | Dec 31, 2013 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: